William Blair & Company
RXII

William Blair & Company’s GALENA BIOPHARMA INC COM RXII Stock Holding History

William Blair & Company’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-10,000
Closed -$17K – 1657
2015
Q2 		$17K Hold
10,000
– – ﹤0.01% 2174
2015
Q1 		$13K Hold
10,000
– – ﹤0.01% 2123
2014
Q4 		$15K Hold
10,000
– – ﹤0.01% 2089
2014
Q3 		$20K Hold
10,000
– – ﹤0.01% 2085
2014
Q2 		$30K Hold
10,000
– – ﹤0.01% 2048
2014
Q1 		$25K Hold
10,000
– – ﹤0.01% 2000
2013
Q4 		$49K Buy
+10,000
New +$49K ﹤0.01% 1954

Other funds holding RXII

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return